Monday, January 24, 2022

♟ The 2 Best Defense Plays Your Money Can Buy

Trade of the Day Logo
Stealth Bomber Hero Image

One New Pick. Each Wednesday. 77% Win Rate. See How to Get It Now

"There is no easier way to make money in the market than to buy a great company under pressure due to short-term concerns." - T. Rowe Price portfolio manager David Giroux, on Barron's Roundtable

Bryan Bottarelli, Head Trade Tactician, Monument Traders Alliance

Bryan Bottarelli

Today's message is simple...

Right now, we have the combination of a major market sell-off and tensions between Russia and Ukraine that are getting worse by the day.

When you add them both together, it's clear that now is the time to reallocate your portfolio in the defense/aerospace sector.

What's the best way to do that?

I believe there are two superior ways to get exposure to the entire sector - all in one shot.

The first play is more conservative.

It's the iShares U.S. Aerospace & Defense ETF (BATS: ITA).

1 Trade Idea Delivered Every Week

Watch This
 

83% win rate and a guarantee he beats that!

Has this former CBOE trader lost his mind??

Watch this immediately.

Here are the ETF's top 10 holdings.

  • Raytheon 19.71%
  • Boeing 18.63%
  • Lockheed Martin 5.55%
  • Teledyne 5.01%
  • L3Harris Technologies 4.83%
  • General Dynamics 4.73%
  • Northrop Grumman 4.51%
  • TransDigm Group 4.47%
  • Textron 4.26%
  • Howmet Aerospace 3.51%

And here's a chart showing its recent performance:

Aerospace Defense ETF Daily Performance
 

For $100 per share, you get a basket of the market's top aerospace and defense companies.

The second play is more speculative.

It's the Direxion Daily Aerospace & Defense Bull 3X Shares ETF (NYSE: DFEN).

This is a defense fund that invests 80% of its assets into financial instruments and securities that track the performance of the aerospace and defense industry of the U.S. equity market.

It moves at a rate of 3X the defense/aerospace sector and could represent a cheap but highly leveraged way to get positioned in the entire sector.

Logo

YOUR ACTION PLAN

With a confrontation between Russia and Ukraine looking more inevitable by the day (which would most certainly be met with some sort of U.S. response), I believe that having some exposure to the defense/aerospace sector makes a lot of tactical sense.

Depending on whether you're a conservative investor or a speculative trader, I've offered two options above that'll fit your risk-tolerance profile.

How did we play this in The War Room? Join us today to find out - and to claim 322 winners guaranteed over the next year!

20X Bigger Than Big Tech?

Revenue Growth
 

Forget Coins... Tokens... and Crypto Funds...

This Tiny Crypto STOCK Could Dominate the Stock Market in 2022.

Click Here to Discover Why

Chart

MONDAY MARKET MINUTE

  • The Energy Select Sector SPDR Fund (NYSE: XLE) is worth monitoring due to inflationary pressure. It offers exposure to best-of-breed companies like Exxon Mobil (NYSE: XOM), Chevron (NYSE: CVX), EOG Resources (NYSE: EOG) and ConocoPhillips (NYSE: COP). Tracking.
  • Defense stocks look ready to run, as a Russian invasion of Ukraine seems inevitable. A conservative play would be the iShares U.S. Aerospace & Defense ETF (BATS: ITA).
  • Last week, we noted in The War Room that a huge number of stocks had already crashed. This is not the time to be selling quality. If you are positioned properly and have cash on hand, opportunities abound. Join us in The War Room now to seize them!

 

INSIGHTS YOU MAY HAVE MISSED

Worried Businessman Hero Image

Did Your Fund Panic This Week?

Donald Trump Hero Image

If You Missed the First Shot at Trump's Stock Last Week... Here's Part 2

Two Picks Are Better Than One Hero Image

Market Anxiety Triggers 2 New Value Picks

Growth Stocks Vs Value Stocks Hero Image

The No. 1 Market Question: Growth vs. Value – ANSWERED

Instagram

Follow Us on Instagram!

FACEBOOK

TWITTER

 

No comments:

Post a Comment

Press Release from NCI: Researchers uncover new role of mutant RAS proteins in some of the deadliest cancers

The latest press release from the National Cancer Institute Having trouble viewing this email?...